Back to the Supreme | GenomeWeb

Back to the Supreme

The gene patenting fight is heading back to the US Supreme Court, the Associated Press reports. According to ScienceInsider, the court added that it will only consider the issue of whether human genes are "patent-eligible."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.